Differential effects of recombinant interferon α on constitutive and inducible cytochrome P450 isozymes in mouse liver
References (50)
Cytochrome P-450s: Polymorphic multigene families involved in carcinogen activation
Trends Genetics
(1986)Effect of interferon inducers and viral infection on the metabolism of drugs
Adv Immunopharmacol
(1981)- et al.
Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents
Biochem Biophys Res Commun
(1976) - et al.
Sequential administrations of polyriboinosinic acid and polyribocytodylic acid induce interferon and depress the hepatic cytochrome P-450-dependent monooxygenase system
Biochem Biophys Res Commun
(1982) - et al.
Selective depression of hepatic cytochrome P-450 hemoprotein by interferon inducers
Biochem Biophys Res Commun
(1980) - et al.
Protein measurement with the Folin phenol reagent
J Biol Chem
(1951) - et al.
The carbon monoxide binding pigment of liver microsomes: I. Evidence for its hemoprotein nature
J Biol Chem
(1964) - et al.
Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization and kinetic studies
J Biol Chem
(1962) - et al.
Effects of storage on hepatic microsomal cytochromes and substrate-induced difference spectra
Biochem Pharmacol
(1970) - et al.
Isolation of a high-spin form of cytochrome P-450 induced in rat liver by 3-methylcholanthrene
Biochem Biophys Res Commun
(1983)
Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation
Biochem Biophys Res Commun
(1982)
Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450
Biochem Pharmacol
(1984)
Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450
Biochem Pharmacol
(1985)
Isozyme-specific phosphorylation of cytochromes P-450 and other drug-metabolizing enzymes
Biochem Biophys Res Commun
(1987)
Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers poly rI.rC and tilorone
Biochem Biophys Res Commun
(1979)
The influence of recombinant DNA-derived human and murine gamma interferons on mouse hepatic drug metabolism
Fund Appl Toxicol
(1986)
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy
Cancer Res
(1988)
Drug metabolism under pathological and abnormal physiological states in animals and man
Xenobiotica
(1977)
Relation between the enzymes of detoxication and host defense mechanisms
Some properties of interferons induced by stimulants of T and B lymphocytes
Tex Rep Biol Med
(1977)
Interferon-induced alterations in cells: relevance to viral and non-viral diseases
Lab Invest
(1983)
Induction and inducers of interferon
Decrease in the activity of the drug-metaboliing enzymes of rat liver following the administration of tilorone hydrochloride
Drug Metab Dispos
(1976)
Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation
Mol Pharmacol
(1891)
The pharmacology and toxicology of the interferons: an overview
Annu Rev Pharmacol Toxicol
(1986)
Cited by (43)
Fragrances as a trigger of immune responses in different environments
2024, Toxicology in VitroInteractions between immune and biotransformation systems in fish: A review
2008, Aquatic ToxicologyThe cytochromes P450 (CYP) response to allergic inflammation of the lung
2006, Archives of Biochemistry and BiophysicsPossible implication of macrophages in the regulation of cytochrome P450 activities in carp (Cyprinus carpio)
2006, Fish and Shellfish ImmunologyCitation Excerpt :Ethoxycoumarin-O-deethylase (ECOD) activity was decreased by TNFα in the liver, kidney, intestine and lung but not in heart and spleen [14]. Different results were obtained in the regulation of cytochrome P450 in liver and spleen in comparison with kidney after interferon administration [38]. It seems that in fish and mammals, a differential regulation between organs exists when animals are treated with immunomodulating agents.
Hepatic (dys-)function during inflammation
2003, Toxicology in Vitro
- †
Present address: Mail Drop C3-03, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, U.S.A.
Copyright © 1991 Published by Elsevier Inc.